Is a complete KRYS research report available?

No complete published report is available for Krystal Biotech, Inc. (KRYS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Krystal Biotech, Inc. (KRYS)

NASDAQ: KRYS · USD

$321

-0.03 (-0.0%)· Recorded snapshot

Market cap	9.5B
Revenue (ttm)	440.5M
Net income (ttm)	241.5M
EPS (ttm)	$7.97
Shares out	29.6M
P/E (trailing)	40.2x
P/E (forward)	40.7x
Volume	161,323
Beta	0.50

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Metric	Value
Amount currency	USD
CIK code	0001711279
Company name	Krystal Biotech, Inc.
Country	United States
Country code	US
CUSIP number	501147102
Earnings date	2026-11-02
Earnings time	bmo
Employees	295
Employees change	20
Employees growth	7.27%
Enterprise value	$8.4B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2017-09-20
Is primary listing	Yes
Is SPAC	No
ISIN number	US5011471027
Last 10-K release date	2026-02-17
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$9.5B
Market cap category	Mid-Cap
Next earnings date	2026-11-02
Options	Yes
Price	$320.54
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	KRYS
U.S. state	Pennsylvania
Website	https://www.krystalbio.com

Metric

Value

Amount currency

USD

CIK code

0001711279

Company name

Krystal Biotech, Inc.

Country

United States

Country code

CUSIP number

501147102

Earnings date

2026-11-02

Earnings time

bmo

Employees

295

Employees change

Employees growth

7.27%

Enterprise value

$8.4B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2015

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2017-09-20

Is primary listing

Yes

Is SPAC

ISIN number

US5011471027

Last 10-K release date

2026-02-17

Last earnings date

2026-08-03

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$9.5B

Market cap category

Mid-Cap

Next earnings date

2026-11-02

Options

Yes

Price

$320.54

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

KRYS

U.S. state

Pennsylvania

Website

https://www.krystalbio.com

Metric	Value
Adjusted P/E ratio	40.17x
Average P/E ratio (3Y)	74.23x
Earnings yield	2.49%
EV/Earnings	34.82x
EV/EBIT	42.52x
EV/EBITDA	42.19x
EV/FCF	32.62x
EV/Sales	19.09x
FCF / EV yield	3.07%
FCF yield	2.71%
Forward EV/Sales	15.27x
Forward P/E	40.74x
Forward P/S	17.26x
Graham number	90.72287
Graham upside	-71.74%
P/(FCF - SBC) ratio	46.79x
P/(OCF - SBC) ratio	43.66x
P/B ratio	6.98x
P/E ratio	40.24x
P/FCF ratio	36.86x
P/OCF ratio	34.89x
P/S ratio	21.57x
PEG ratio	0.93x
Price / tangible book value	6.99x
Price/EBITDA ratio	47.68x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

40.17x

Average P/E ratio (3Y)

74.23x

Earnings yield

2.49%

EV/Earnings

34.82x

EV/EBIT

42.52x

EV/EBITDA

42.19x

EV/FCF

32.62x

EV/Sales

19.09x

FCF / EV yield

3.07%

FCF yield

2.71%

Forward EV/Sales

15.27x

Forward P/E

40.74x

Forward P/S

17.26x

Graham number

90.72287

Graham upside

-71.74%

P/(FCF - SBC) ratio

46.79x

P/(OCF - SBC) ratio

43.66x

P/B ratio

6.98x

P/E ratio

40.24x

P/FCF ratio

36.86x

P/OCF ratio

34.89x

P/S ratio

21.57x

PEG ratio

0.93x

Price / tangible book value

6.99x

Price/EBITDA ratio

47.68x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	44.89%
EBITDA margin	45.24%
FCF margin	58.52%
Gross margin	94.64%
Operating margin	44.89%
Pretax margin	51.45%
Profit margin	54.82%
Profit per employee	$818,522
Profitable quarters	12
Profitable years	3
Revenue per employee	$1.5M
ROA	9.37%
ROA (5Y)	-3.12%
ROCE	14.4%
ROE	20.12%
ROE (5Y)	-1.97%
ROIC	40.16%
ROIC (5Y)	-23.48%
SBC / revenue	12.41%
Tax / revenue	-3.37%

Metric

Value

EBIT margin

44.89%

EBITDA margin

45.24%

FCF margin

58.52%

Gross margin

94.64%

Operating margin

44.89%

Pretax margin

51.45%

Profit margin

54.82%

Profit per employee

$818,522

Profitable quarters

Profitable years

Revenue per employee

$1.5M

ROA

9.37%

ROA (5Y)

-3.12%

ROCE

14.4%

ROE

20.12%

ROE (5Y)

-1.97%

ROIC

40.16%

ROIC (5Y)

-23.48%

SBC / revenue

12.41%

Tax / revenue

-3.37%

Metric	Value
EPS growth	62.4%
EPS growth (Q)	38.76%
EPS growth (QoQ)	-2.19%
EPS growth quarters	7
EPS growth years	3
FCF growth	39.01%
FCF growth (Q)	40.14%
FCF growth (QoQ)	-2.74%
Gross profit growth	24.3%
Gross profit growth (Q)	26.9%
Net income growth	64.57%
Net income growth (Q)	42.87%
Net income growth (QoQ)	-2.08%
Net income growth quarters	7
Net income growth years	3
OCF growth	39.38%
OCF growth (Q)	41.84%
OCF growth (QoQ)	-6.96%
Operating income growth	30.08%
Operating income growth (Q)	48.27%
Revenue growth	22.63%
Revenue growth (Q)	24.14%
Revenue growth (QoQ)	2.46%
Revenue growth quarters	8
Revenue growth years	2

Metric

Value

EPS growth

62.4%

EPS growth (Q)

38.76%

EPS growth (QoQ)

-2.19%

EPS growth quarters

EPS growth years

FCF growth

39.01%

FCF growth (Q)

40.14%

FCF growth (QoQ)

-2.74%

Gross profit growth

24.3%

Gross profit growth (Q)

26.9%

Net income growth

64.57%

Net income growth (Q)

42.87%

Net income growth (QoQ)

-2.08%

Net income growth quarters

Net income growth years

OCF growth

39.38%

OCF growth (Q)

41.84%

OCF growth (QoQ)

-6.96%

Operating income growth

30.08%

Operating income growth (Q)

48.27%

Revenue growth

22.63%

Revenue growth (Q)

24.14%

Revenue growth (QoQ)

2.46%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-14.6M
Depreciation and amortization	$1.5M
EBIT	$197.8M
EBITDA	$199.3M
EPS	$7.97
FCF per share	$8.71
Financing cash flow	$24M
Free cash flow	$257.8M
Free cash flow minus SBC	$203.1M
Gross profit	$416.9M
Income taxes	$-14.8M
Investing cash flow	$-218.3M
Net cash flow	$73.9M
Net income	$241.5M
Operating cash flow minus SBC	$217.7M
Operating income	$197.8M
Revenue	$440.5M
Stock-based compensation	$54.7M

Metric

Value

Capital expenditures

$-14.6M

Depreciation and amortization

$1.5M

EBIT

$197.8M

EBITDA

$199.3M

EPS

$7.97

FCF per share

$8.71

Financing cash flow

$24M

Free cash flow

$257.8M

Free cash flow minus SBC

$203.1M

Gross profit

$416.9M

Income taxes

$-14.8M

Investing cash flow

$-218.3M

Net cash flow

$73.9M

Net income

$241.5M

Operating cash flow minus SBC

$217.7M

Operating income

$197.8M

Revenue

$440.5M

Stock-based compensation

$54.7M

Metric	Value
Altman Z-Score	30.07
Book value per share	$45.92
Debt / EBITDA	0.04
Debt / equity	0.01
Debt / FCF	0.03
Long-term assets	$441M
Long-term liabilities	$14.1M
Net cash (debt)	$1.1B
Net cash / market cap	11.51%
Net cash growth	34.89%
Net debt / EBITDA	-5.49
Net debt / equity	-0.8
Net debt / FCF	-4.24
Piotroski F-Score	5
Property, plant and equipment	$160.6M
Shareholders' equity	$1.4B
Tangible book value	$1.4B
Tangible book value per share	$45.92
Total assets	$1.5B
Total cash	$845.6M
Total debt	$8.9M
Total liabilities	$141.5M
WACC	6.98%

Metric

Value

Altman Z-Score

30.07

Book value per share

$45.92

Debt / EBITDA

0.04

Debt / equity

0.01

Debt / FCF

0.03

Long-term assets

$441M

Long-term liabilities

$14.1M

Net cash (debt)

$1.1B

Net cash / market cap

11.51%

Net cash growth

34.89%

Net debt / EBITDA

-5.49

Net debt / equity

-0.8

Net debt / FCF

-4.24

Piotroski F-Score

Property, plant and equipment

$160.6M

Shareholders' equity

$1.4B

Tangible book value

$1.4B

Tangible book value per share

$45.92

Total assets

$1.5B

Total cash

$845.6M

Total debt

$8.9M

Total liabilities

$141.5M

WACC

6.98%

Metric	Value
Asset turnover	0.33
Current assets	$1.1B
Current liabilities	$127.4M
Current ratio	8.32
Inventory turnover	0.62
Net working capital	$88.4M
Quick ratio	7.73
Working capital	$932.3M
Working capital turnover	0.52

Metric

Value

Asset turnover

0.33

Current assets

$1.1B

Current liabilities

$127.4M

Current ratio

8.32

Inventory turnover

0.62

Net working capital

$88.4M

Quick ratio

7.73

Working capital

$932.3M

Working capital turnover

0.52

Metric	Value
Buyback yield / dilution	-1.46%
Dividend yield	0%
Shareholder yield	-1.46%

Metric

Value

Buyback yield / dilution

-1.46%

Dividend yield

Shareholder yield

-1.46%

Metric	Value
150-day SMA	$321.14
1D price change	-0.01%
1M price change	-7.84%
1M total return	-7.84%
1W price change	-2.06%
1W total return	-2.06%
1Y price change	67.81%
1Y return CAGR	67.87%
1Y total return	67.81%
20-day SMA	$323.78
200-day SMA	$308.15
3M price change	-9.41%
3M total return	-9.41%
3Y price change	179.21%
3Y return CAGR	40.8%
3Y total return	179.21%
50-day SMA	$337.88
50-day SMA vs 200-day SMA	50over200
52-week high	$382.54
52-week high date	2026-06-30
52-week low	$183.26
52-week low date	2025-10-29
5Y price change	499.89%
5Y return CAGR	43.1%
5Y total return	499.89%
6M price change	16.85%
6M total return	16.85%
All-time high	$382.54
All-time high date	2026-06-30
All-time low	$8.03
All-time low date	2017-12-19
Average true range (ATR)	$10.04
Average volume	268.4K
Beta (1Y)	0.78
Beta (2Y)	0.6
Beta (5Y)	0.5
Change from 52-week high	-16.21%
Change from 52-week low	74.91%
Change from all-time high	-16.68%
Change from all-time low	3,869.12%
Change from open	0.15%
Day's gap	-0.17%
Dollar volume	$51.7M
High price	$321.28
Low price	$316.09
Monthly RSI	63.19
Open price	$320.05
Position in 52-week range	85.74%
Premarket change	-1.43%
Premarket close	$320.58
Premarket price	$316.00
Previous close	$320.58
Price vs 150-day SMA	-0.75%
Price vs 20-day SMA	-1.56%
Price vs 200-day SMA	3.43%
Price vs 50-day SMA	-5.67%
Relative volume	0.6
RSI	43.93
Sharpe ratio	1.46
Sharpe ratio (3Y)	0.87
Sharpe ratio (5Y)	0.73
Sortino ratio	2.37
Sortino ratio (3Y)	1.54
Sortino ratio (5Y)	1.71
Volume	161.3K
Weekly RSI	50.56
YTD price change	29.28%
YTD total return	29.28%

Metric

Value

150-day SMA

$321.14

1D price change

-0.01%

1M price change

-7.84%

1M total return

-7.84%

1W price change

-2.06%

1W total return

-2.06%

1Y price change

67.81%

1Y return CAGR

67.87%

1Y total return

67.81%

20-day SMA

$323.78

200-day SMA

$308.15

3M price change

-9.41%

3M total return

-9.41%

3Y price change

179.21%

3Y return CAGR

40.8%

3Y total return

179.21%

50-day SMA

$337.88

50-day SMA vs 200-day SMA

50over200

52-week high

$382.54

52-week high date

2026-06-30

52-week low

$183.26

52-week low date

2025-10-29

5Y price change

499.89%

5Y return CAGR

43.1%

5Y total return

499.89%

6M price change

16.85%

6M total return

16.85%

All-time high

$382.54

All-time high date

2026-06-30

All-time low

$8.03

All-time low date

2017-12-19

Average true range (ATR)

$10.04

Average volume

268.4K

Beta (1Y)

0.78

Beta (2Y)

0.6

Beta (5Y)

0.5

Change from 52-week high

-16.21%

Change from 52-week low

74.91%

Change from all-time high

-16.68%

Change from all-time low

3,869.12%

Change from open

0.15%

Day's gap

-0.17%

Dollar volume

$51.7M

High price

$321.28

Low price

$316.09

Monthly RSI

63.19

Open price

$320.05

Position in 52-week range

85.74%

Premarket change

-1.43%

Premarket close

$320.58

Premarket price

$316.00

Previous close

$320.58

Price vs 150-day SMA

-0.75%

Price vs 20-day SMA

-1.56%

Price vs 200-day SMA

3.43%

Price vs 50-day SMA

-5.67%

Relative volume

0.6

RSI

43.93

Sharpe ratio

1.46

Sharpe ratio (3Y)

0.87

Sharpe ratio (5Y)

0.73

Sortino ratio

2.37

Sortino ratio (3Y)

1.54

Sortino ratio (5Y)

1.71

Volume

161.3K

Weekly RSI

50.56

YTD price change

29.28%

YTD total return

29.28%

Metric	Value
Float	23.6M
Float percentage	79.8%
Shares change (QoQ)	0.49%
Shares change (YoY)	1.46%
Shares held by insiders	9.94%
Shares held by institutions	92.28%
Shares outstanding	29.6M
Short % of float	14.72%
Short % of shares	11.74%
Short ratio	12.5 days

Metric

Value

Float

23.6M

Float percentage

79.8%

Shares change (QoQ)

0.49%

Shares change (YoY)

1.46%

Shares held by insiders

9.94%

Shares held by institutions

92.28%

Shares outstanding

29.6M

Short % of float

14.72%

Short % of shares

11.74%

Short ratio

12.5 days

Krystal Biotech, Inc. (KRYS)

Price

Financial snapshot

Fair-value bridge

Latest news · KRYS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KRYS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on KRYS

Frequently asked questions